InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,261.20
(
0.51%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
86.53
(
1.67%
)
Bitcoin
62,932.69
(
0.53%
)
Post# of 252453
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rkrw

Send PM Follow Ignore
Followers 45
Posts 3204
Boards Moderated 0
Alias Born 12/29/2003

rkrw

Member Level

Re: drbio45 post# 97464

Saturday, 06/19/2010 10:10:57 AM

Saturday, June 19, 2010 10:10:57 AM

Post# of 252453
What basis do you have for saying it's "better" than the other approved HAE drugs?

The half life of Rhucin, 3 hours, is unsuitable for prevention so that nixes the better than Cinryze.

For acute, I don't know how you can compare since they haven't been tested head to head. Rhucin is effective for treating attacks but a quick look at the data showed a median time to sympton relief of about 30 minutes for Cinryze (and I assume similar for CSL) versus 1-2 hours for Rhucin.



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up